Aristolochia bracteolata Lam.’s Toxicity Profile and Neuroprotective Effects in Mice with Memory Impairment Triggered by Scopolamine
- 1,
- 2*,
- 3,
- 4,
- 4
- 1Department of Biomedical Science, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.
- 2Department of Pharmacy Practice, KMCH College of Pharmacy, Coimbatore, Tamil Nadu, India.
- 3Department of Pharmacology, Faculty of Allied Health Sciences, Meenakshi Academy of Higher Education and Research, Kanchipuram, Tamil Nadu, India.
- 4Department of Pharmaceutical Technology, Centre for Excellence in Nanobio Translational Research Center, Anna University, Bharathidasan Institute of Technology Campus, Tiruchirappalli, Tamil Nadu, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Swathy Govindaswamy
Department of Pharmacy Practice, KMCH College of Pharmacy, Coimbatore, Tamil Nadu, India.
Email: swathy@kmchcop.ac.in
Copyright: © 2023 The Author(s). This is an open access article.
Published: Jan 1, 2023, Received: Oct 10, 2023, Accepted: Nov 2, 2023
Abstract
Aim: The present study aims to investigate the toxicity profile and neuroprotective effect of ethanol crude extract of Aristolochia bracteolata (EEAB) leaves in mice.
Materials and Methods: EEAB was subjected to preliminary phytochemical screening and gas chromatography–mass spectrometry (GC–MS) analysis. To determine the toxicity profile in Swiss albino mice, acute and subchronic toxicity experiments were performed according to Organisation for Economic Co-operation and Development criteria. A behavioral test in mice with drug-induced learning and memory impairment was performed to determine neuroprotective effects.
Results: In the study GC–MS, 19 compounds were detected. Compared to the control group, no clinical signs of toxicity were detected in the plant-treated group in both the acute and subchronic toxicity experiments at the highest dose of 2,000 mg/ kg. It was calculated that the mean oral lethal dose (LD50) > was 2,000 mg/kg. Scopolamine-induced cognitive deficits in mice were greatly reduced after pretreatment with the EEAB at a dose of 100 mg/kg p.o. This was demonstrated by the reversal of the improvement in spontaneous alternation in the Y-maze task and by the significant improvement in latency in the passive avoidance task.
Conclusion: Based on the results, EEAB might contain potent secondary metabolites that would primarily enhance the neuroprotective effects and cognitive deficits induced by cholinergic dysfunction.
Keywords
Subject
Recommended articles
- Review on Exploring Role of Vitamin D on Alzheimer’s Disease: Mechanistic Insights and Implications
Nagaraju Bandaru, Mohan Gandhi Bonthu, Alluri Pavani Gayatri · Journal of Pharmacology and Pharmacotherapeutics
- A Comprehensive Analysis of Use of Small Laboratory Animals in Preclinical Research: A Five-Year Quantitative Descriptive Analysis
Ajay Gattani, Komal Khurade, Raakhi Tripathi · Journal of Pharmacology and Pharmacotherapeutics
- A Deep Insight into the Correlation Between Gut Dysbiosis and Alzheimer’s Amyloidopathy
Sreenivasulu Naidu Kondaveeti, Dithu Thekkekkara, Lakshmi T Narayanan · Journal of Pharmacology and Pharmacotherapeutics
- Neuroprotective Effects of P-Coumaric Acid on Haloperidol-Induced Catalepsy Through Ameliorating Oxidative Stress and Brain Dopamine Level
Afsar S. Pathan, Pankaj G. Jain, Vivek S. Kumawat · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026